| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| Feb 17, 2022 | Feb 22, 2022 | Shah Jatin EVP Chief Medical Officer | Sell | Karyopharm Therapeutics Inc. | KPTI | $12.12 | $15,833 | -1.00% |
| Feb 07, 2022 | Feb 09, 2022 | Shah Jatin EVP Chief Medical Officer | Sell | Karyopharm Therapeutics Inc. | KPTI | $9.86 | $16,805 | -1.29% |
| May 07, 2021 | May 11, 2021 | Shah Jatin EVP Chief Medical Officer | Buy | Karyopharm Therapeutics Inc. | KPTI | $8.6 | $199,992 | +14.99% |
| Feb 18, 2021 | Feb 23, 2021 | Shah Jatin EVP Chief Medical Officer | Sell | Karyopharm Therapeutics Inc. | KPTI | $14.83 | $17,590 | -2.24% |
| Feb 11, 2021 | Feb 17, 2021 | Shah Jatin EVP Chief Medical Officer | Sell | Karyopharm Therapeutics Inc. | KPTI | $15.52 | $27,127 | -3.19% |
| Jul 15, 2020 | Nov 05, 2020 | Shah Jatin EVP Chief Medical Officer | Sell | Karyopharm Therapeutics Inc. | KPTI | $19.46 | $11,462 | -1.34% |
| Feb 19, 2020 | Feb 21, 2020 | Shah Jatin EVP Chief Medical Officer | Sell | Karyopharm Therapeutics Inc. | KPTI | $16.48 | $22,663 | -3.26% |
| Mar 13, 2015 | Mar 17, 2015 | Shah Jatin SVP Chief Scientific Offic | Sell | Perrigo Co Plc | PRGO | $165.5 | $331,000 | -37.80% |